Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of drug targeting (Print)

• Publication date

  2009-12-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3109/10611860903156419PMID 19637935
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ligand-based targeted therapy for cancer tissue

  2009cited by this paper
• Targeted therapy of cancer: new roles for pathologists in colorectal cancer

  2008cited by this paper
• Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel

  2008cited by this paper
• Design of Folate-Linked Liposomal Doxorubicin to its Antitumor Effect in Mice

  2008cited by this paper
• Liposomal Nanomedicines: An Emerging Field

  2008cited by this paper
• Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer.

  2008cited by this paper
• Mimicking nature's nanocarrier: synthetic low-density lipoprotein-like nanoparticles for cancer-drug delivery.

  2007cited by this paper
• Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme.

  2007cited by this paper
• Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs

  2007cited by this paper
• Trojan Horse Meets Magic Bullet to Spawn a Novel, Highly Effective Drug Delivery Model

  2006cited by this paper
• Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme.

  2006cited by this paper
• Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents.

  2005influential reference
• A Mutant High-Density Lipoprotein Receptor Inhibits Proliferation of Human Breast Cancer Cells

  2004cited by this paper
• Normal and pathological human testes express hormone-sensitive lipase and the lipid receptors CLA-1/SR-BI and CD36.

  2004cited by this paper
• Trophoblast-like human choriocarcinoma cells serve as a suitable in vitro model for selective cholesteryl ester uptake from high density lipoproteins.

  2003cited by this paper
• High density lipoprotein complexes as delivery vehicles for anticancer drugs.

  2002cited by this paper
• Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects

  2000cited by this paper
• The human breast carcinoma cell line HBL-100 acquires exogenous cholesterol from high-density lipoprotein via CLA-1 (CD-36 and LIMPII analogous 1)-mediated selective cholesteryl ester uptake.

  2000cited by this paper
• Cholesteryl Ester Transfer Protein Mediates Selective Uptake of High Density Lipoprotein Cholesteryl Esters by Human Adipose Tissue*

  1997cited by this paper
• Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor

  1996cited by this paper
• Cancer and hypocholesterolemia.

  1994cited by this paper
• Expression cloning of SR-BI, a CD36-related class B scavenger receptor.

  1994cited by this paper
• Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells.

  1993cited by this paper
• Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.

  1992cited by this paper
• Uptake of low-density lipoprotein by malignant cells--possible therapeutic applications.

  1991cited by this paper
• Total and HDL cholesterol in human hematologic neoplasms.

  1991cited by this paper
• Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy.

  1990cited by this paper
• Density gradient ultracentrifugation of serum lipoproteins in a swinging bucket rotor.

  1986cited by this paper
• Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents.

  1982cited by this paper
• Separation of plasma lipoproteins by density-gradient ultracentrifugation.

  1975cited by this paper

• A Spontaneous Assembling Lipopeptide Nanoconjugate Transporting the Anthracycline Drug N-Benzyladriamycin-14-valerate for Personalized Therapy of Ewing Sarcoma.

  2024cites this paper
• Nanoparticle Targeting in Chemo‐Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance

  2024cites this paper
• Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy

  2024cites this paper
• Mannose-functionalization of reconstituted high-density lipoprotein nanoparticles improves payload delivery and enhances M2-to-M1 phenotype reprogramming of RAW 264.7 macrophages polarized by B16-F10 melanoma cells

  2023cites this paper
• HDL-Chitosan Nanoparticles for siRNA Delivery as an SR-B1 Receptor Targeted System

  2023cites this paper
• Nanodiscs: Game changer nano-therapeutics and structural biology tools

  2023cites this paper
• Identification of hub genes to determine drug-disease correlation in breast carcinomas

  2023cites this paper
• Structural Optimization of siRNA Conjugates for Albumin Binding Achieves Effective MCL1-Targeted Cancer Therapy

  2023cites this paper
• Ganglioside GM3-Functionalized Reconstituted High-Density Lipoprotein (GM3-rHDL) as a Novel Nanocarrier Enhances Antiatherosclerotic Efficacy of Statins in apoE−/− C57BL/6 Mice

  2022cites this paper
• Lipoprotein interactions with water-soluble NIR-II emitting aza-BODIPYs boost the fluorescence signal and favor selective tumor targeting.

  2022cites this paper
• Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment.

  2022cites this paper
• Expression of SR-B1 receptor in breast cancer cell lines, MDAMB-468 and MCF-7: Effect on cell proliferation and apoptosis

  2021influential citation
• Nanoparticulate systems and their translation potential for breast cancer therapeutics

  2021cites this paper
• Exploring the Therapeutic Potential of the Bioinspired Reconstituted High Density Lipoprotein Nanostructures.

  2021cites this paper
• Recent Advances in the Use of Lipid-Based Nanoparticles Against Glioblastoma Multiforme

  2021cites this paper
• Biomimetic camouflage delivery strategies for cancer therapy.

  2021cites this paper
• Macrophage imaging and subset analysis using single-cell RNA sequencing

  2021cites this paper
• Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy

  2021cites this paper
• Connecting Cholesterol Efflux Factors to Lung Cancer Biology and Therapeutics

  2021cites this paper
• Enhanced Anti-Atherosclerotic Efficacy of pH-Responsively Releasable Ganglioside GM3 Delivered by Reconstituted High-Density Lipoprotein

  2021cites this paper
• Targeted photodynamic therapy using reconstituted high-density lipoproteins as rhodamine transporters.

  2021cites this paper
• Occupational health and safety measures of multifunctional nanoparticles in biomedical research and beyond

  2021cites this paper
• Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy.

  2020cites this paper
• SR-BI as a target of natural products and its significance in cancer.

  2020cites this paper
• Nano-therapeutics for modulating the tumour microenvironment: Design, development, and clinical translation.

  2020cites this paper
• A systematic review of the biodistribution of biomimetic high-density lipoproteins in mice.

  2020cites this paper
• Prognostic role of lipids, apolipoproteins in patients with resectable hepatocellular carcinoma

  2020cites this paper
• Super Duplex Stainless Steel (SDSS)

  2020cites this paper
• Lipoproteins and the Tumor Microenvironment.

  2020cites this paper
• Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma

  2020cites this paper
• Reconfiguring Nature’s Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents

  2020influential citation
• Role of Lipids and Apolipoproteins in Predicting the Prognosis of Hepatocellular Carcinoma After Resection

  2020cites this paper
• HDLs extract lipophilic drugs from cells 1

  2020cites this paper
• From Endocytosis to Nonendocytosis: The Emerging Era of Gene Delivery.

  2020cites this paper
• Lipoproteins-nanocarriers as a Promising Approach for Targeting Liver Cancer: Present Status and Application Prospects.

  2020cites this paper
• HDLs extract lipophilic drugs from cells

  2020cites this paper
• The role of high‐density lipoproteins in antitumor drug delivery

  2019cites this paper
• [99mTc-HYNIC-N-dodecylamide]: a new hydrophobic tracer for labelling reconstituted high-density lipoproteins (rHDL) for radioimaging.

  2019cites this paper
• Role of Lipoproteins in the Microenvironment of Hormone-Dependent Cancers.

  2019cites this paper
• DDDT_A_202818 2043..2055

  2019cites this paper
• In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid-polymeric hybrid nano-system for leukemia therapy

  2019cites this paper
• Supramolecular Assembly of High-Density Lipoprotein Mimetic Nanoparticles Using Lipid-Conjugated Core Scaffolds.

  2019cites this paper
• The SR-B1 Receptor as a Potential Target for Treating Glioblastoma

  2019cites this paper
• An update on synthetic high-density lipoprotein-like nanoparticles for cancer therapy

  2019cites this paper
• THE ROLE OF LIPOPROTEINS IN THE MICROENVIRONMENT OF HORMONE-1 DEPENDENT CANCERS 2 3

  2019cites this paper
• Tailoring Porphyrin Conjugation for Nanoassembly-Driven Phototheranostic Properties.

  2019cites this paper
• High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme.

  2019cites this paper
• Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy

  2018cites this paper
• Experimental challenges regarding the in vitro investigation of the nanoparticle-biocorona in disease states.

  2018cites this paper
• Targeted delivery of garcinia glycosides by reconstituted high-density lipoprotein nano-complexes

  2018cites this paper
• High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in lung adenocarcinoma

  2018cites this paper
• Lipoproteins for therapeutic delivery: recent advances and future opportunities.

  2018cites this paper
• Scavenger receptor class B type 1 regulates neuroblastoma cell proliferation, migration and invasion.

  2018cites this paper
• Endocytosis of lipoproteins.

  2018cites this paper
• Trends towards Biomimicry in Theranostics

  2018cites this paper
• Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery

  2018cites this paper
• SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux.

  2018cites this paper
• Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer

  2017cites this paper
• Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma

  2017cites this paper
• Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery

  2017cites this paper
• SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer

  2017cites this paper
• Multifunctional Dextran Sulfate-Coated Reconstituted High Density Lipoproteins Target Macrophages and Promote Beneficial Antiatherosclerotic Mechanisms.

  2017cites this paper
• Synthetic Lipoproteins as Carriers for Drug Delivery.

  2016cites this paper
• Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery.

  2016cites this paper
• High-density lipoprotein-biomimetic nanocarriers for glioblastoma-targeting delivery: the effect of shape.

  2016cites this paper
• A peptide-lipid nanoparticle assembly platform with integrated functions for targeted cell delivery.

  2016cites this paper
• High-Density Lipoproteins for Therapeutic Delivery Systems.

  2016cites this paper
• Targeting SR-BI for Cancer Diagnostics, Imaging and Therapy

  2016cites this paper
• Multidrug resistance P-glycoprotein dampens SR-BI cholesteryl ester uptake from high density lipoproteins in human leukemia cells.

  2016influential citation
• High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

  2016cites this paper
• Evaluation of reconstituted high-density lipoprotein (rHDL) as a drug delivery platform - a detailed survey of rHDL particles ranging from biophysical properties to clinical implications.

  2016cites this paper
• High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer

  2016cites this paper
• Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin

  2016cites this paper
• Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging

  2016cites this paper
• Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.

  2016cites this paper
• Nanoscale Drug Delivery Systems: A Current Review on the Promising Paclitaxel Formulations for Future Cancer Therapy

  2015cites this paper
• Learning from biology: synthetic lipoproteins for drug delivery.

  2015cites this paper
• Implications of scavenger receptors in the safe development of nanotherapeutics.

  2015cites this paper
• HDL as a drug and nucleic acid delivery vehicle

  2015cites this paper
• Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation.

  2015cites this paper
• Apolipoprotein A-I and Cancer

  2015cites this paper
• Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology.

  2015cites this paper
• Suppression of Remodeling Behaviors with Arachidonic Acid Modification for Enhanced in vivo Antiatherogenic Efficacies of Lovastatin-loaded Discoidal Recombinant High Density Lipoprotein

  2015cites this paper
• Dual-functional bio-derived nanoparticulates for apoptotic antitumor therapy.

  2015cites this paper
• Cholesterol Modified Self-Assemblies and Their Application to Nanomedicine.

  2015cites this paper
• Reconstituted high density lipoprotein-based nanoparticles: an overview of applications in regenerative medicine, preparation, evaluation and future trends.

  2015cites this paper
• Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging

  2015cites this paper
• Therapeutic potential of nanocarrier for overcoming to P-glycoprotein

  2014cites this paper
• High‐Density Lipoprotein Nanoparticles Deliver RNAi to Endothelial Cells to Inhibit Angiogenesis

  2014cites this paper
• Targeted Nanoparticles for Pediatric Leukemia Therapy

  2014cites this paper
• Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.

  2014cites this paper
• Nanoparticle-enabled, image-guided treatment planning of target specific RNAi therapeutics in an orthotopic prostate cancer model.

  2014cites this paper
• Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D in vitro evaluation.

  2014cites this paper
• Nanopharmacology in translational hematology and oncology

  2014cites this paper
• Incorporation of photosenzitizer hypericin into synthetic lipid-based nano-particles for drug delivery and large unilamellar vesicles with different content of cholesterol

  2014cites this paper
• A pH-responsive high density lipoprotein-like nanoparticle of epothilone B

  2014cites this paper
• 10.19 – Smart-Drug Delivery and Target-Specific Therapy

  2014cites this paper
• Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery.

  2013influential citation
• The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics

  2013cites this paper
• Scavenger Receptor B1 is a Potential Biomarker of Human Nasopharyngeal Carcinoma and Its Growth is Inhibited by HDL-mimetic Nanoparticles

  2013cites this paper